Seborrheic Dermatitis
Conditions
Interventions
Scalp Oil-Control and Balancing Complex Acids Group:The subjects in this group used Ximeien scalp oil control balance compound acid once a week for a total of 4 times.
Selenium Sulfide Lotion:Topical application of selenium sulfide lotion, twice a week for a total of eight applications.
Complete Scalp Care Products Group:Topical application of Oil-Control Balancing Complex Acids (once a week, total of 4 applications), along with Oil-Control Anti-Dandruff Shampoo (twice a week, total
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1.Patients diagnosed with scalp seborrheic dermatitis based on the diagnostic criteria outlined in the Chinese Dermatology and Venereology (Clinical Edition). 2.Aged 18 to 60 years, regardless of gender. 3.Clinical manifestations of scalp seborrheic dermatitis, including erythema, papules, scales, pruritus, and greasiness on the scalp. 4.Dermoscopic evidence of scalp seborrheic dermatitis, such as inflammatory papules, erythema, vascular dilation, and scaling. 5.Patients who are willing to participate in the study and have signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients who have a history of treatment of scalp seborrheic dermatitis, including oral or topical medications, other acid-based products, or functional scalp care products within the past two weeks. 2.Patients who have a history of allergy to any ingredient in the products used in this study. 3.Refusal to accept or rejection of the study protocol. 4.Presence of hyperthyroidism, hypothyroidism, severe malnutrition, endocrine disorders, autoimmune diseases, or other major diseases involving organs such as the heart, liver, lungs, or brain. 5.Patients who have a history of psychiatric disorders or mental illness. 6.Pregnant or breastfeeding women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Erythema Severity Score;Papule Severity Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Observation, Recording, and Management of Adverse Events; | — |
Countries
China
Contacts
Public ContactMao Lin
West China Hospital, Sichuan University
Outcome results
None listed